Hrd-positive
Pneumonitis may lead to death.īefore taking LYNPARZA, tell your healthcare provider about all of your medical conditions, including if you: Your healthcare provider may temporarily or completely stop treatment if you develop pneumonitis. Your healthcare provider may do a chest x-ray if you have any of these symptoms. Tell your healthcare provider if you have any new or worsening symptoms of lung problems, including shortness of breath, fever, cough, or wheezing. Your healthcare provider may stop treatment with LYNPARZA until your blood cell counts improve
See the links below to the Summary of Safety and Effectiveness Data (SSED) and product labeling for more complete information on this product, its indications for use, and the basis for FDA’s approval.
This is a brief overview of information related to FDA’s approval to market this product.